SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-001482
Filing Date
2024-02-13
Accepted
2024-02-13 16:33:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 UNIQURE N.V. p24-0810sc13g.htm SC 13G 58292
2 JOINT ACQUISITION STATEMENT exhibit99.htm EX-99.1 4286
  Complete submission text file 0000902664-24-001482.txt   64162
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Subject) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88012 | Film No.: 24626661
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

IRS No.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G